We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Association between antenatal corticosteroid treatment and severe adverse events in pregnant women

    Background

    Antenatal corticosteroids are considered the standard of care for pregnant women at risk for preterm birth, but studies examining their...

    Hui-Ju Tsai, Beth I. Wallace, ... Tsung-Chieh Yao in BMC Medicine
    Article Open access 31 October 2023
  2. Corticosteroid treatment for acute hydrocephalus in neurosarcoidosis: a case report

    Background

    Neurosarcoidosis occurs symptomatically in 5–10% of patients with sarcoidosis, and hydrocephalus is a rare complication of...

    Edoardo Dalmato Schilke, Giulia Remoli, ... Maura Frigo in Journal of Medical Case Reports
    Article Open access 13 February 2024
  3. Influence of corticosteroid treatment on CXCR4 expression in DLBCL

    Background

    CXCR4-targeted radioligand therapy (RLT) with [ 177 Lu]Lu/[ 90 Y]Y-PentixaTher has recently evolved as a promising therapeutic option for...

    Sebastian Martin, David Viertl, ... Margret Schottelius in EJNMMI Research
    Article Open access 10 May 2023
  4. Corticosteroid in anti-inflammatory treatment of pediatric acute myocarditis: a systematic review and meta-analysis

    Background

    To evaluate the efficacy of corticosteroids in anti-inflammatory treatment of pediatric acute myocarditis.

    Methods

    We searched PubMed,...

    Qi Yao, Shanshan Zhan in Italian Journal of Pediatrics
    Article Open access 13 March 2023
  5. Extra-corporeal shock wave therapy versus local corticosteroid injection in treatment of chronic trigger finger in diabetic patients

    Background

    Trigger finger is one of the most common causes of pain and dysfunction. The aim of our study was to compare the effectiveness of shock...

    Sally A. El-Leithy, Nahla Nader Adly, ... Nermin H. El-Gharbawy in Egyptian Rheumatology and Rehabilitation
    Article Open access 13 November 2023
  6. Efficacy and Safety of Corticosteroid in Combination with 5-Fluorouracil in the Treatment of Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis

    Background

    Addressing hypertrophic scars and keloids poses a significant challenge in the realm of preventive and curative medicine. Combination...

    Jianzhen Shi, Siqi Zhang, ... Siyu Sun in Aesthetic Plastic Surgery
    Article 11 July 2024
  7. Corticosteroid-associated osteonecrosis of the femoral head in an 87-year-old patient following treatment for COVID-19-associated pneumonia: A case report

    Coronavirus disease 2019 is known to cause severe acute respiratory syndrome, and serious cases need to be treated with corticosteroids. Herein, we...

    Fumihiro Yoshimura, Kenichiro Doi, ... Takuaki Yamamoto in Skeletal Radiology
    Article 08 April 2024
  8. Dynamic interplay between corticosteroid treatment and the role of SRC-1 gene dysregulation in the progression of WHO-Grade 4 Astrocytoma

    Background

    Corticosteroid is commonly used before surgery to control cerebral oedema in brain tumours and is frequently continued throughout...

    Maher Kurdi, Motaz M Fadul, ... Saleh Baeesa in Journal of Neuro-Oncology
    Article Open access 04 July 2023
  9. Platelet-Rich Plasma Versus Corticosteroid Injection in the Treatment of Arthropathic Chronic Low Back Pain: Systematic Review and Meta-analysis

    Purpose of Review

    Low back pain (LBP) is the leading cause of global disability. Recently, there has been an interest in using platelet-rich plasma...

    Elver S. Ho, Anusha Lekshminarayanan, ... Derek J. Ho in Current Physical Medicine and Rehabilitation Reports
    Article 01 May 2023
  10. Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study)

    Data about the impact of Belimumab on corticosteroid sparing in real life are scarce. To assess the corticosteroid-sparing effect among patients with...

    Marie Jaïs, Pascal Roblot, ... Amandine Perier in Rheumatology International
    Article 30 April 2024
  11. Corticosteroid treatment in severe patients with SARS-CoV-2 and chronic HBV co-infection: a retrospective multicenter study

    Background

    The impact of corticosteroids on patients with severe coronavirus disease 2019 (COVID-19)/chronic hepatitis B virus (HBV) co-infection is...

    Mei Meng, Yufeng Chu, ... Dechang Chen in BMC Infectious Diseases
    Article Open access 28 November 2022
  12. Corticosteroid treatment for refractory intracranial hypertension: a rescue therapy in patients with severe traumatic brain injury with contusional lesions—a feedback

    Introduction

    Refractory intracranial hypertension (rICH) is a severe complication among patients with severe traumatic brain injury (sTBI). Medical...

    Sophie Menat, Alice Jacquens, ... Vincent Degos in Acta Neurochirurgica
    Article 18 February 2023
  13. Combined arthroscopic release with corticosteroid hydrodilatation versus corticosteroid hydrodilatation only in treating freezing-phase primary frozen shoulder: a randomized clinical trial

    Background

    There has been no ideal treatment for freezing-phase frozen shoulder to rapidly relieve pain and improve joint mobility. No any other team...

    Zhu Dai, Quanhui Liu, ... Chao Liu in BMC Musculoskeletal Disorders
    Article Open access 17 December 2022
  14. Hyaluronic Acid and Platelet-Rich Plasma Mixture Versus Hyaluronic Acid and Corticosteroid in the Treatment of Temporomandibular Joint Internal Derangement: A Comparative Randomized Study

    Objectives

    This study aimed to compare the effects of different intra-articular injections using a mixture of hyaluronic acid (HA) and platelet-rich...

    Amira A. M. M. Attia, Sally S. Awad in Journal of Maxillofacial and Oral Surgery
    Article 05 April 2023
  15. Practice patterns regarding regional corticosteroid treatment in noninfectious Uveitis: a survey study

    Background

    Regional corticosteroid therapy for noninfectious uveitis is well-established but usage patterns have not been studied extensively. This...

    Matthew McHarg, LeAnne Young, ... Shilpa Kodati in Journal of Ophthalmic Inflammation and Infection
    Article Open access 04 January 2022
  16. Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn’s disease

    To induce remission in luminal paediatric Crohn’s disease (CD), the ESPGHAN/ECCO guideline recommends treatment with exclusive enteral nutrition...

    Maria M. E. Jongsma, Stephanie A. Vuijk, ... Lissy de Ridder in European Journal of Pediatrics
    Article Open access 08 June 2022
  17. Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis

    Introduction

    Long-term corticosteroid use in immune-mediated diseases is associated with increased risk of adverse events (AEs) and worsened...

    Kyle Hayes, John Niewoehner, ... George J. Wan in Advances in Therapy
    Article Open access 20 September 2023
  18. A case report of severe systemic herpes simplex virus-1 (HSV-1) infection with multi-organ involvement after a course of oral corticosteroid treatment

    Background

    Herpes simplex virus (HSV) rarely causes organ-invasive infection. Diagnosis and treatment for such infections are often delayed, and...

    Myeongji Kim, Ayesha Jalal, ... Romina Bromberg in BMC Infectious Diseases
    Article Open access 05 November 2022
  19. Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

    Background

    Tofacitinib is an oral, small molecule JAK inhibitor for the treatment of UC. We aimed to describe the real-world treatment experience and...

    Michael V. Chiorean, Jessica R. Allegretti, ... Nabeel Khan in BMC Gastroenterology
    Article Open access 09 April 2022
  20. Favorable course of leptospirosis and hantavirus-induced acute tubulointerstitial nephritis under corticosteroid treatment

    Background

    We present two children with acute tubulointerstitial nephritis (ATIN) caused by leptospirosis in a 12-year-old boy and hantavirus in a...

    Annelies Matthys, Jo Dehoorne, ... Agnieszka Prytuła in Pediatric Nephrology
    Article 10 April 2023
Did you find what you were looking for? Share feedback.